0.2272
price down icon4.82%   -0.0115
 
loading
전일 마감가:
$0.2387
열려 있는:
$0.245
하루 거래량:
196.46K
Relative Volume:
0.03
시가총액:
$10.21M
수익:
$3.50M
순이익/손실:
$-37.33M
주가수익비율:
-0.2272
EPS:
-1
순현금흐름:
$-19.15M
1주 성능:
-24.27%
1개월 성능:
-36.31%
6개월 성능:
-49.57%
1년 성능:
-85.62%
1일 변동 폭
Value
$0.2178
$0.245
1주일 범위
Value
$0.2178
$0.296
52주 변동 폭
Value
$0.2103
$2.52

Hcw Biologics Inc Stock (HCWB) Company Profile

Name
명칭
Hcw Biologics Inc
Name
전화
954-842-2024
Name
주소
2929 N COMMERCE PKWY, MIRAMAR
Name
직원
0
Name
트위터
Name
다음 수익 날짜
2025-04-01
Name
최신 SEC 제출 서류
Name
HCWB's Discussions on Twitter

HCWB을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
HCWB
Hcw Biologics Inc
0.2272 10.21M 3.50M -37.33M -19.15M -1.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

Hcw Biologics Inc 주식(HCWB)의 최신 뉴스

pulisher
Apr 03, 2025

HCW Biologics Stock Set to Reverse Split on Friday, April 11th (NASDAQ:HCWB) - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

HCW Biologics to Implement 1-for-40 Reverse Stock Split - MarketScreener

Apr 02, 2025
pulisher
Apr 01, 2025

HCW Biologics approves reverse stock split to meet Nasdaq rules By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

HCW Biologics approves reverse stock split - Investing.com India

Apr 01, 2025
pulisher
Apr 01, 2025

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Apr 01, 2025
pulisher
Apr 01, 2025

HCW Biologics approves reverse stock split to meet Nasdaq rules - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

HCW Biologics approves 1-for-40 reverse stock split - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

HCW Biologics Announces 1-For-40 Reverse Stock Split - MarketScreener

Apr 01, 2025
pulisher
Apr 01, 2025

HCW Biologics Announces 1-for-40 Reverse Stock Split - GlobeNewswire

Apr 01, 2025
pulisher
Apr 01, 2025

Major Stock Restructuring: HCW Biologics Announces 40:1 Reverse Split for Nasdaq Compliance - Stock Titan

Apr 01, 2025
pulisher
Apr 01, 2025

Warner Bros Discovery Stock (NASDAQ:WBD) Slides as Film Boss Replacements Considered - The Globe and Mail

Apr 01, 2025
pulisher
Mar 30, 2025

HCW BIOLOGICS Earnings Preview: Recent $HCWB Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 30, 2025
pulisher
Mar 29, 2025

HCW Biologics Reports Fourth Quarter and Fiscal Year 2024 Business Highlights and Financial Results - GlobeNewswire

Mar 29, 2025
pulisher
Mar 28, 2025

HCW Biologics Inc. SEC 10-K Report - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

HCW Biologics Secures FDA Green Light for Alopecia Treatment Despite $30M Annual Loss - Stock Titan

Mar 28, 2025
pulisher
Mar 19, 2025

HCW Biologics amends agreement with WY Biotech amid delays - Investing.com

Mar 19, 2025
pulisher
Mar 11, 2025

Stocks Attempt to Stabilize as Trump Set to Meet with Top US Executives - The Globe and Mail

Mar 11, 2025
pulisher
Mar 07, 2025

HCW Biologics Granted Extension by the Nasdaq Hearings - GlobeNewswire

Mar 07, 2025
pulisher
Mar 06, 2025

HCW Biologics Inc. Receives Extension from Nasdaq to Regain Compliance with Listing Rules - Nasdaq

Mar 06, 2025
pulisher
Mar 06, 2025

Can HCW Biologics Meet Nasdaq's New June Deadline? Key Details Revealed - StockTitan

Mar 06, 2025
pulisher
Feb 24, 2025

HCW Biologics Inc. announced that it expects to receive $20 million in funding -February 19, 2025 - Marketscreener.com

Feb 24, 2025
pulisher
Feb 24, 2025

Zeta (ZETA) Q4 Earnings: What To Expect - The Globe and Mail

Feb 24, 2025
pulisher
Feb 10, 2025

HCW Biologics Inc (HCWB) is looking forward to a strong quarter - SETE News

Feb 10, 2025
pulisher
Feb 10, 2025

HCW Biologics Inc Inc. (HCWB) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle

Feb 10, 2025
pulisher
Feb 10, 2025

Navigating the Volatility of HCW Biologics Inc’s (HCWB) Stock - The News Heater

Feb 10, 2025
pulisher
Feb 06, 2025

Trading Day Review: HCW Biologics Inc (HCWB) Loses Momentum, Closing at 0.43 - The Dwinnex

Feb 06, 2025
pulisher
Feb 05, 2025

The Business Case For Buying HCW Biologics Inc (NASDAQ: HCWB) Stock Now - Stocks Register

Feb 05, 2025
pulisher
Feb 05, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Feb 05, 2025
pulisher
Feb 04, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Feb 04, 2025
pulisher
Feb 04, 2025

HCW Biologics: Buy Rating Affirmed Amid IND Clearance and Strategic Advancements - TipRanks

Feb 04, 2025
pulisher
Feb 04, 2025

HCW-9302 gains IND clearance for first-in-human study in alopecia areata - BioWorld Online

Feb 04, 2025
pulisher
Feb 04, 2025

Why Palantir Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket - Benzinga

Feb 04, 2025
pulisher
Feb 03, 2025

HCW Biologics Inc Inc. (HCWB) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle

Feb 03, 2025
pulisher
Feb 03, 2025

Penny Stocks To ResearchFebruary 03rd - MarketBeat

Feb 03, 2025
pulisher
Feb 03, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Feb 03, 2025
pulisher
Feb 03, 2025

Pharma company granted FDA clearance for alopecia drug study - The Business Journals

Feb 03, 2025
pulisher
Feb 03, 2025

Crude Oil Moves Higher; Owens & Minor Shares Plummet - Benzinga

Feb 03, 2025
pulisher
Feb 03, 2025

FDA approves HCW Biologics trial for alopecia treatment - MSN

Feb 03, 2025
pulisher
Feb 03, 2025

What's Going On With HCW Biologics Stock Monday? - Benzinga

Feb 03, 2025
pulisher
Feb 03, 2025

A Potential Breakthrough in the Fight Against Alopecia Areata: What You Need to Know About HCW Biologics Inc. - RagingBull

Feb 03, 2025
pulisher
Feb 03, 2025

Stock market news: MDJM surged by 74.54% while Tonix Pharmaceuticals Holding plunged by 49.31% during mid day trading - Business Upturn

Feb 03, 2025
pulisher
Feb 03, 2025

Dow Falls 150 Points; ISM Manufacturing PMI Rises In January - Benzinga

Feb 03, 2025
pulisher
Feb 03, 2025

S&P 500 Down Over 1%; Tyson Foods Posts Upbeat Results - Benzinga

Feb 03, 2025
pulisher
Feb 03, 2025

HCW Biologics Advances with FDA Clearance for Trial - TipRanks

Feb 03, 2025
pulisher
Feb 03, 2025

Stock market today: Tonix Pharmaceuticals Holding declined by 49.01% whereas HCW Biologics jumped by 176.78% in early trading - Business Upturn

Feb 03, 2025
pulisher
Feb 03, 2025

HCW Biologics Says FDA Approves Trial of HCW9302 to Treat Alopecia Areata; Shares Rise Pre-Bell - Marketscreener.com

Feb 03, 2025
pulisher
Feb 03, 2025

HCW Biologics Granted FDA Clearance to Evaluate One of the - GlobeNewswire

Feb 03, 2025
pulisher
Feb 03, 2025

HCW Biologics Granted FDA Clearance to Evaluate One of the Company?s Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial - Marketscreener.com

Feb 03, 2025
pulisher
Jan 30, 2025

HCWB stock touches 52-week low at $0.25 amid market challenges - Investing.com Australia

Jan 30, 2025
pulisher
Jan 30, 2025

HCW Biologics (NASDAQ:HCWB) Shares Down 20% – Here’s Why - Defense World

Jan 30, 2025
pulisher
Jan 29, 2025

HCWB stock touches 52-week low at $0.25 amid market challenges By Investing.com - Investing.com South Africa

Jan 29, 2025

Hcw Biologics Inc (HCWB) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
자본화:     |  볼륨(24시간):